Tuesday, December 12, 2017 10:13:42 PM
FDA_will_Approve_OMHE’s_PRESCRIPTION_CBD_based_Pain_Medicine_in_2018
In Feb 2017 OMHE shared its vision and indicated its plan on working on therapeutic cannabis products and licensed medical marijuana cultivation.
CLICK HERE TO READ FEB 2017 OMHE VISION & FUTURE PLANS
Specialty pharmaceuticals..........................Completed
Anti-aging brands.......................................Completed
Therapeutic cannabis products..................Completed
Licensed medical marijuana cultivation......COMING SOON
Remember, OMHE can acquire a MMJ Cultivation License holder company!!!
In 2018 OMHE PPS IS HEADING TO $1
Made Thousands into Millions..Now in Tens of Millions
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM